|
|
Gene Symbol |
TP53 |
|
Aliases |
BCC7, BMFS5, LFS1, P53, TRP53 |
|
Entrez Gene ID |
|
|
Gene Name |
Tumor protein p53 |
|
Chromosomal Location |
17p13.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
NM_001276695.2, NM_001276696.2, NM_001276697.2, NM_001276698.2, NM_001276699.2, NM_001276760.2, NM_001276761.2, NM_000546.5, NM_001126112.2, NM_001126114.2, NM_001126113.2, NM_001126115.1, NM_001126116.1, NM_001126117.1, NM_001126118.1 |
|
e!Ensembl
Gene |
|
|
Transcript |
ENST00000413465, ENST00000635293, ENST00000359597, ENST00000504290, ENST00000510385, ENST00000504937, ENST00000619186, ENST00000618944, ENST00000610623, ENST00000610292, ENST00000269305, ENST00000620739, ENST00000455263, ENST00000420246, ENST00000622645, ENST00000610538, ENST00000445888, ENST00000619485, ENST00000576024, ENST00000509690, ENST00000514944, ENST00000508793, ENST00000604348, ENST00000503591, ENST00000617185, ENST00000615910 |
|
Protein |
ENSP00000410739, ENSP00000488924, ENSP00000352610, ENSP00000484409, ENSP00000478499, ENSP00000481179, ENSP00000484375, ENSP00000481401, ENSP00000477531, ENSP00000478219, ENSP00000269305, ENSP00000481638, ENSP00000398846, ENSP00000391127, ENSP00000482222, ENSP00000480868, ENSP00000391478, ENSP00000482537, ENSP00000458393, ENSP00000425104, ENSP00000423862, ENSP00000424104, ENSP00000473895, ENSP00000426252, ENSP00000482258, ENSP00000482903
|
|
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000122 |
Biological process |
Negative regulation of transcription by RNA polymerase II |
ISS |
19749791 |
GO:0000733 |
Biological process |
DNA strand renaturation |
IDA |
8183576 |
GO:0002244 |
Biological process |
Hematopoietic progenitor cell differentiation |
IMP |
30146126 |
GO:0006284 |
Biological process |
Base-excision repair |
TAS |
15116721 |
GO:0006289 |
Biological process |
Nucleotide-excision repair |
IMP |
7663514 |
GO:0006355 |
Biological process |
Regulation of transcription, DNA-templated |
IDA |
7587074 |
GO:0006355 |
Biological process |
Regulation of transcription, DNA-templated |
IMP |
25417702 |
GO:0006914 |
Biological process |
Autophagy |
IMP |
23629966 |
GO:0006974 |
Biological process |
Cellular response to DNA damage stimulus |
IDA |
14744935, 15710329, 17938203 |
GO:0006974 |
Biological process |
Cellular response to DNA damage stimulus |
IMP |
24356969 |
GO:0006977 |
Biological process |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
IMP |
16213212 |
GO:0006978 |
Biological process |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
IDA |
16213212 |
GO:0006978 |
Biological process |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
IMP |
7958916, 16479015 |
GO:0006983 |
Biological process |
ER overload response |
IDA |
14744935 |
GO:0007050 |
Biological process |
Cell cycle arrest |
IDA |
15149599 |
GO:0007050 |
Biological process |
Cell cycle arrest |
IMP |
7958916, 10962037 |
GO:0007265 |
Biological process |
Ras protein signal transduction |
IEP |
9054499 |
GO:0007275 |
Biological process |
Multicellular organism development |
IMP |
10065150 |
GO:0007569 |
Biological process |
Cell aging |
IMP |
12080348 |
GO:0008104 |
Biological process |
Protein localization |
IDA |
16507995 |
GO:0008283 |
Biological process |
Cell proliferation |
TAS |
10065150 |
GO:0008285 |
Biological process |
Negative regulation of cell proliferation |
IDA |
22783376 |
GO:0008285 |
Biological process |
Negative regulation of cell proliferation |
IMP |
12730672 |
GO:0009299 |
Biological process |
MRNA transcription |
IMP |
16479015 |
GO:0010332 |
Biological process |
Response to gamma radiation |
IMP |
7958916 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IDA |
15314173, 20332243 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IMP |
19160485 |
GO:0016032 |
Biological process |
Viral process |
IMP |
22574148 |
GO:0030154 |
Biological process |
Cell differentiation |
TAS |
10065150 |
GO:0030308 |
Biological process |
Negative regulation of cell growth |
IMP |
8986812 |
GO:0030330 |
Biological process |
DNA damage response, signal transduction by p53 class mediator |
IDA |
15149599 |
GO:0030330 |
Biological process |
DNA damage response, signal transduction by p53 class mediator |
IMP |
20160708 |
GO:0031497 |
Biological process |
Chromatin assembly |
IDA |
16322561 |
GO:0031571 |
Biological process |
Mitotic G1 DNA damage checkpoint |
IMP |
7958916 |
GO:0032461 |
Biological process |
Positive regulation of protein oligomerization |
IDA |
12667443 |
GO:0034644 |
Biological process |
Cellular response to UV |
IDA |
16213212, 23629966 |
GO:0035690 |
Biological process |
Cellular response to drug |
IEP |
20810912 |
GO:0042149 |
Biological process |
Cellular response to glucose starvation |
IDA |
14744935, 21471221 |
GO:0042771 |
Biological process |
Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
IDA |
14654789, 14744935, 17403783 |
GO:0042771 |
Biological process |
Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
IMP |
16213212 |
GO:0042981 |
Biological process |
Regulation of apoptotic process |
IDA |
14744935 |
GO:0043065 |
Biological process |
Positive regulation of apoptotic process |
IDA |
12667443, 15565177, 20959462 |
GO:0043066 |
Biological process |
Negative regulation of apoptotic process |
IMP |
20124405 |
GO:0045892 |
Biological process |
Negative regulation of transcription, DNA-templated |
IDA |
24051492 |
GO:0045892 |
Biological process |
Negative regulation of transcription, DNA-templated |
IMP |
23629966 |
GO:0045892 |
Biological process |
Negative regulation of transcription, DNA-templated |
ISS |
19749791 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IDA |
16322561, 17403783, 18549481, 20378837 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IMP |
20096447 |
GO:0045899 |
Biological process |
Positive regulation of RNA polymerase II transcriptional preinitiation complex assembly |
IDA |
24289924 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
11672523, 17145718, 17310983, 17599062, 18549481, 20959462, 24652652 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IGI |
16061649 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IMP |
17146433, 24356969 |
GO:0046677 |
Biological process |
Response to antibiotic |
IEP |
20810912 |
GO:0046902 |
Biological process |
Regulation of mitochondrial membrane permeability |
TAS |
15116721 |
GO:0048147 |
Biological process |
Negative regulation of fibroblast proliferation |
IMP |
10962037 |
GO:0048539 |
Biological process |
Bone marrow development |
IMP |
30146126 |
GO:0050731 |
Biological process |
Positive regulation of peptidyl-tyrosine phosphorylation |
ISS |
19749791 |
GO:0051097 |
Biological process |
Negative regulation of helicase activity |
TAS |
7663514 |
GO:0051123 |
Biological process |
RNA polymerase II preinitiation complex assembly |
IDA |
24289924 |
GO:0051262 |
Biological process |
Protein tetramerization |
TAS |
15116721 |
GO:0051289 |
Biological process |
Protein homotetramerization |
IDA |
19011621 |
GO:0051289 |
Biological process |
Protein homotetramerization |
IMP |
15629713 |
GO:0051974 |
Biological process |
Negative regulation of telomerase activity |
IDA |
10597287 |
GO:0060218 |
Biological process |
Hematopoietic stem cell differentiation |
IMP |
30146126 |
GO:0065003 |
Biological process |
Protein-containing complex assembly |
IDA |
12915590 |
GO:0071158 |
Biological process |
Positive regulation of cell cycle arrest |
IDA |
15314173 |
GO:0071158 |
Biological process |
Positive regulation of cell cycle arrest |
IMP |
21471221 |
GO:0071456 |
Biological process |
Cellular response to hypoxia |
IEP |
20810912 |
GO:0071479 |
Biological process |
Cellular response to ionizing radiation |
IMP |
20160708 |
GO:0071480 |
Biological process |
Cellular response to gamma radiation |
IDA |
16213212 |
GO:0072331 |
Biological process |
Signal transduction by p53 class mediator |
IDA |
15314173 |
GO:0072332 |
Biological process |
Intrinsic apoptotic signaling pathway by p53 class mediator |
IMP |
12172011, 16322561, 17310983 |
GO:0072717 |
Biological process |
Cellular response to actinomycin D |
IDA |
15314173 |
GO:0090200 |
Biological process |
Positive regulation of release of cytochrome c from mitochondria |
IDA |
12667443, 14963330 |
GO:0090399 |
Biological process |
Replicative senescence |
IMP |
19951988 |
GO:0090403 |
Biological process |
Oxidative stress-induced premature senescence |
IMP |
19951988 |
GO:0097193 |
Biological process |
Intrinsic apoptotic signaling pathway |
TAS |
16462759 |
GO:0097252 |
Biological process |
Oligodendrocyte apoptotic process |
IDA |
7720704 |
GO:1900119 |
Biological process |
Positive regulation of execution phase of apoptosis |
IMP |
14985081 |
GO:1902895 |
Biological process |
Positive regulation of pri-miRNA transcription by RNA polymerase II |
IDA |
20546595 |
GO:1903800 |
Biological process |
Positive regulation of production of miRNAs involved in gene silencing by miRNA |
IDA |
26100857 |
GO:2000379 |
Biological process |
Positive regulation of reactive oxygen species metabolic process |
IMP |
20160708 |
GO:2001244 |
Biological process |
Positive regulation of intrinsic apoptotic signaling pathway |
IMP |
14963330, 27031958 |
GO:0000790 |
Cellular component |
Nuclear chromatin |
IDA |
15710329, 17805299, 22521434, 23629966, 24289924 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
7720704, 14744935, 14963330, 16322561, 16507995, 17403783, 18756595, 19011621, 19234109, 20096447, 20810912, 24101517, 24289924 |
GO:0005634 |
Cellular component |
Nucleus |
IMP |
16479015 |
GO:0005654 |
Cellular component |
Nucleoplasm |
IDA |
11080164, 12915590 |
GO:0005667 |
Cellular component |
Transcription factor complex |
IGI |
17145718 |
GO:0005669 |
Cellular component |
Transcription factor TFIID complex |
IDA |
15053879 |
GO:0005730 |
Cellular component |
Nucleolus |
IDA |
12080348 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
7720704, 14744935, 16131611, 19011621, 20096447, 20810912, 23629966 |
GO:0005737 |
Cellular component |
Cytoplasm |
IMP |
16479015 |
GO:0005739 |
Cellular component |
Mitochondrion |
IDA |
12667443, 24101517 |
GO:0005829 |
Cellular component |
Cytosol |
IDA |
14963330, 24101517 |
GO:0016363 |
Cellular component |
Nuclear matrix |
IDA |
11080164 |
GO:0016604 |
Cellular component |
Nuclear body |
IDA |
10360174 |
GO:0016605 |
Cellular component |
PML body |
IDA |
12006491, 22869143 |
GO:0032991 |
Cellular component |
Protein-containing complex |
IDA |
9529249, 17310983 |
GO:0032991 |
Cellular component |
Protein-containing complex |
IMP |
15629713 |
GO:0000978 |
Molecular function |
RNA polymerase II proximal promoter sequence-specific DNA binding |
IDA |
24289924 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
IDA |
17310983, 24289924, 24652652 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISM |
19274049 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
NAS |
19274049 |
GO:0001046 |
Molecular function |
Core promoter sequence-specific DNA binding |
IDA |
23629966 |
GO:0001085 |
Molecular function |
RNA polymerase II transcription factor binding |
IPI |
18549481 |
GO:0001094 |
Molecular function |
TFIID-class transcription factor complex binding |
IPI |
24289924 |
GO:0001228 |
Molecular function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IDA |
17145718, 17146433 |
GO:0002020 |
Molecular function |
Protease binding |
IPI |
11923872 |
GO:0002039 |
Molecular function |
P53 binding |
IPI |
25417702 |
GO:0003677 |
Molecular function |
DNA binding |
IDA |
15358771 |
GO:0003677 |
Molecular function |
DNA binding |
IMP |
2144364, 15629713 |
GO:0003682 |
Molecular function |
Chromatin binding |
IDA |
16322561, 17599062 |
GO:0003700 |
Molecular function |
DNA-binding transcription factor activity |
IDA |
7587074, 18549481 |
GO:0003700 |
Molecular function |
DNA-binding transcription factor activity |
IMP |
16479015 |
GO:0003730 |
Molecular function |
MRNA 3'-UTR binding |
IDA |
16213212 |
GO:0005507 |
Molecular function |
Copper ion binding |
IDA |
7824276 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
1465435, 7663514, 7799929, 8207801, 8344494, 8675009, 8875926, 8875929, 9050995, 9188558, 9194564, 9194565, 9380510, 9472015, 9529249, 9807817, 9827557, 10196247, 10226625, 10518217, 10597287, 10608892, 10823891, 11080164, 11146555, 11178989, 11359905, 11388671, 11427532, 11672523, 11 |
GO:0005524 |
Molecular function |
ATP binding |
IDA |
8183576 |
GO:0008134 |
Molecular function |
Transcription factor binding |
IPI |
15053879, 15705871, 19505873 |
GO:0008270 |
Molecular function |
Zinc ion binding |
TAS |
10065153 |
GO:0019899 |
Molecular function |
Enzyme binding |
IPI |
7663514, 10666337, 11672523, 11781842, 15044383, 15577914, 17805299, 20173098 |
GO:0019901 |
Molecular function |
Protein kinase binding |
IPI |
11546806, 21317932 |
GO:0019903 |
Molecular function |
Protein phosphatase binding |
IPI |
20562916 |
GO:0030971 |
Molecular function |
Receptor tyrosine kinase binding |
IPI |
23027130 |
GO:0031625 |
Molecular function |
Ubiquitin protein ligase binding |
IPI |
8875929, 9529249, 10415337, 17121812, 18382127 |
GO:0035035 |
Molecular function |
Histone acetyltransferase binding |
IPI |
9194565, 10518217 |
GO:0042802 |
Molecular function |
Identical protein binding |
IMP |
15629713 |
GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
14985081, 16291740, 16461914, 17612295, 17620598, 18087040, 19339993, 19667193, 20004160, 20159469, 20364130, 21178074, 21522129, 21988832, 22653443, 22972749, 25402006, 25609649 |
GO:0042803 |
Molecular function |
Protein homodimerization activity |
IDA |
19011621 |
GO:0042826 |
Molecular function |
Histone deacetylase binding |
IPI |
23629966 |
GO:0043621 |
Molecular function |
Protein self-association |
IPI |
14985081 |
GO:0044212 |
Molecular function |
Transcription regulatory region DNA binding |
IDA |
15710329, 17996705 |
GO:0046982 |
Molecular function |
Protein heterodimerization activity |
IPI |
10837489 |
GO:0047485 |
Molecular function |
Protein N-terminus binding |
IPI |
11861836 |
GO:0051087 |
Molecular function |
Chaperone binding |
IPI |
15358771, 18086682 |
GO:0051721 |
Molecular function |
Protein phosphatase 2A binding |
IPI |
17245430 |
GO:0097718 |
Molecular function |
Disordered domain specific binding |
IPI |
15629713 |
GO:1990841 |
Molecular function |
Promoter-specific chromatin binding |
IDA |
20725088, 24356969 |
|
Protein Information |
|
Protein Name |
Cellular tumor antigen p53, antigen NY-CO-13, mutant tumor protein 53, p53 tumor suppressor, phosphoprotein p53, transformation-related protein 53, tumor protein 53, tumor supressor p53 |
|
Function |
Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed:12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed:12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492). |
|
|
|
NP_001263624.1, NP_001263625.1, NP_001263626.1, NP_001263627.1, NP_001263628.1, NP_001263689.1, NP_001263690.1, NP_000537.3, NP_001119584.1, NP_001119586.1, NP_001119585.1, NP_001119587.1, NP_001119588.1, NP_001119589.1, NP_001119590.1
|
|
UniProt |
|
|
PDB |
3LW1, 5MHC, 5MOC, 1YCS, 2MEJ, 1JSP, 1H26, 2K8F, 2MZD, 5XZC, 2LY4, 3OQ5, 1YCR, 4HFZ, 2MWY, 3DAB, 5UN8, 1A1U, 1AIE, 1C26, 1DT7, 1GZH, 1HS5, 1KZY, 1MA3, 1OLG, 1OLH, 1PES, 1PET, 1SAE, 1SAF, 1SAK, 1SAL, 1TSR, 1TUP, 1UOL, 1XQH, 1YC5, 1YCQ, 2AC0, 2ADY, 2AHI, 2ATA, 2B3G, 2BIM, 2BIN, 2BIO, 2BIP, 2BIQ, 2F1X, 2FEJ, |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000371040 |
|
|
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Blood Disorders |
Anemia |
|
Myelodysplastic Syndrome |
|
Cardiovascular Diseases |
Cardiomyopathy |
|
Hypertensive disease |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Chromosome 17p Deletion Syndrome |
|
Digestive System Diseases |
Liver Diseases |
|
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Ovarian Cancer |
|
Glioma |
|
Li-Fraumeni Syndrome |
23625637, 18307025, 15925506, 26094658, 10864200, 19806023, 17308077, 26845104, 8527048, 9598730, 24033266, 27328919, 1679237, 25925845, 24573247, 22829111, 26270727, 21059199, 11479205, 27374712, 23897043, 17390010, 20967502, 9766574, 1467311, 26534844, 19012332, 16007150, 17606709, 25186627, 21305319, 1565144, 11139324, 15977174, 22672556, 9764816, 25741868, 23161690, 21601526, 26014290, 17311302, 25787918, 15221755, 9047394, 16633321, 10484981, 25326637, 1631137, 1644930, 26452166, 10922393, 21626334, 16494995, 21552135, 20689556, 12826609, 21761402, 1737852, 8825920, 1933902, 1978757, 7887414, 2259385, 9452042, 8718514, 8401536, 1565143, 1349175, 23891399 |
Breast Cancer |
15802278, 17388661, 26192916, 16968874, 26229107, 26619011, 16489069, 24884479, 23469205, 22698404, 9569050, 8364550, 1673792, 25741868, 28877932 |
Prostate cancer |
|
Genital Neoplasms, Male |
|
Heriditary Neoplastic Syndrome |
25925845, 9569035, 26641009, 22887876, 15781632, 21561095, 24382691, 16489069, 26022348, 26086041, 7799951, 23056405, 24814347, 28026089, 24728327, 11429705, 18489080, 22187033, 27553368, 24700732, 19714490, 27458004, 19046423, 9242456, 24835218, 20593220, 20522432, 27501770, 125092 |
Colonic Neoplasms |
|
Adrenal Cancer |
9815696, 23585556, 24747642, 26619011, 26822237, 16033918, 11753428, 15121773, 18762572, 11600572, 11481490, 15741269, 24747643, 25741868 |
Renal Cancer |
|
Leukemia |
|
Lung Cancer |
26192916, 17325666, 16410370, 20727180, 11798837, 26619011, 22941188, 22941189, 23435014, 24688052, 17290066, 26928227 |
Bladder Cancer |
|
Nasopharyngeal Cancer |
|
Carcinoma |
9626339, 17450239, 24403052, 11511317, 26950094, 21946351, 25855136, 27539887, 24224046, 17979968, 17290066, 22484628, 11798837, 10797276, 22929185 |
Stomach Cancer |
|
Nephroblastoma |
|
Colorectal Cancer |
|
Adenocarcinoma |
|
Central Nervous System Neoplasms |
|
Intestinal Cancer |
|
Thymoma |
|
Thyroid Cancer |
|
Endometrial Cancer |
|
Osteosarcoma |
|
Intrahepatic Cholangiocarcinoma |
|
Liver Cancer |
16410370, 12378512, 1672732, 15004724, 25157968, 25741868, 26619011, 8033108, 9029167, 17191126, 18477611, 25822088, 22675488 |
Head Neoplasms |
|
Choroid Plexus Carcinoma |
|
Lymphoma |
|
Neuroblastoma |
|
Choroid Plexus Papilloma |
|
Adenoma |
|
Gall Bladder Cancer |
|
Cribriform Carcinoma |
|
Extrahepatic Cholangiocarcinoma |
|
Sarcoma |
|
Brain Stem Glioma |
|
Adenocarcinoma of Prostate |
|
Gastric Cancer |
|
Mouth Neoplasms |
|
Glioblastoma Multiforme |
|
Esophagus Neoplasm |
|
Pancreatic Neoplasm |
|
Genitourinary Cancer |
|
Ctaneous Melanoma |
|
Medulloblastoma |
|
Multiple Myeloma |
|
Hepatoblastoma |
|
Bilateral Wilms Tumor |
|
Head and Neck Neoplasms |
|
Skin Cancer |
|
Adenocarcinoma Of Pancreas |
|
Adenoid Cystic Carcinoma |
|
Astrocytoma |
|
Leukemia, megakaryoblastic, of Down syndrome |
|
Carotid Atherosclerosis |
|
Cholangiocarcinoma |
|
Hematologic Neoplasms |
|
Anaplastic Carcinoma |
|
Glioblastoma |
|
Urinary Tract Cancer |
|
Brain Neoplasms |
|
Hemangioma |
|
Carcinoma of Skin |
|
Vulvar Cancer |
30415992, 28536037, 30291345, 27834349, 16998595, 17373116, 8183560, 15603096, 7503188, 9062165, 29140881, 27359057, 8995554, 28527674, 9445189, 17300232, 10091798, 11441690, 10989637, 25072932, 10716158, 10389975, 24048714, 26855143, 28144815, 12090585, 28461034, 26171917, 12801263 |
Nervous System Diseases |
Moyamoya disease |
|
Demyelinating Diseases |
|
Arsenic Encephalopathy |
|
Carotid Artery Diseases |
|
Lateral Sclerosis |
|
Cerebral Ischemia |
|
Psychiatric/Brain disorders |
Schizophrenia |
|
Renal Disorder |
Kidney Insufficiency |
|
Balkan Nephropathy |
|
Kidney Failure |
|
Reproductive disorders |
Male infertility |
|
Vulvar Lichen Sclerosus |
|
Subfertility, Female |
|
Preeclampsia |
|
Respiratory Tract Diseases |
Airway Obstruction |
|
Chronic Obstructive Pulmonary Disease |
|
Skin and Connective Tissue Diseases |
Keratosis |
|
Psoriasis |
|
Pustulosis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
BRCA1, BRCA2 |
Hyperandrogenism, acne, hirsutism, obesity, oligoanovulation and infertility, insulin resistance |
rs1042522?G/C |
Rotterdam consensus criteria |
Direct
|
One hundred and ten women of reproductive age with PCOS and one hundred and thirty healthy women |
TheTP53andBRCA1may constitute an inheritable risk factor for PCOS in South Indian women |
|
|
|